DK1296671T3 - Gabapentinanaloger til sövnforstyrrelser - Google Patents

Gabapentinanaloger til sövnforstyrrelser

Info

Publication number
DK1296671T3
DK1296671T3 DK01939192T DK01939192T DK1296671T3 DK 1296671 T3 DK1296671 T3 DK 1296671T3 DK 01939192 T DK01939192 T DK 01939192T DK 01939192 T DK01939192 T DK 01939192T DK 1296671 T3 DK1296671 T3 DK 1296671T3
Authority
DK
Denmark
Prior art keywords
sleep disorders
gabapentin analogues
gabapentin
analogues
compounds
Prior art date
Application number
DK01939192T
Other languages
Danish (da)
English (en)
Inventor
Leonard Theodore Meltzer
Justin Stephen Bryans
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK1296671T3 publication Critical patent/DK1296671T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01939192T 2000-06-26 2001-05-18 Gabapentinanaloger til sövnforstyrrelser DK1296671T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21417100P 2000-06-26 2000-06-26
PCT/US2001/016343 WO2002000209A2 (fr) 2000-06-26 2001-05-18 Analogues de gabapentine pour traiter les troubles du sommeil

Publications (1)

Publication Number Publication Date
DK1296671T3 true DK1296671T3 (da) 2008-06-16

Family

ID=22798045

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01939192T DK1296671T3 (da) 2000-06-26 2001-05-18 Gabapentinanaloger til sövnforstyrrelser

Country Status (24)

Country Link
US (1) US7141606B2 (fr)
EP (1) EP1296671B1 (fr)
JP (1) JP3909842B2 (fr)
KR (1) KR100785182B1 (fr)
CN (1) CN1279900C (fr)
AT (1) ATE390133T1 (fr)
AU (2) AU2001264736B2 (fr)
BR (1) BR0111913A (fr)
CA (1) CA2414008C (fr)
CZ (1) CZ20024110A3 (fr)
DE (1) DE60133389T2 (fr)
DK (1) DK1296671T3 (fr)
ES (1) ES2300332T3 (fr)
HK (1) HK1056681A1 (fr)
HU (1) HUP0300833A3 (fr)
IL (2) IL152770A0 (fr)
MX (1) MXPA02010668A (fr)
NZ (1) NZ522480A (fr)
PL (1) PL359872A1 (fr)
PT (1) PT1296671E (fr)
SK (1) SK17922002A3 (fr)
TW (1) TWI298020B (fr)
WO (1) WO2002000209A2 (fr)
ZA (1) ZA200209418B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2444053C (fr) 2001-04-19 2008-06-17 Warner-Lambert Company Llc Acides amnines bicycliques ou tricycliques fondus
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7420002B2 (en) 2001-06-11 2008-09-02 Xenoport Amino acid conjugates providing for sustained systemic concentrations of GABA analogues
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
EP1404324B2 (fr) 2001-06-11 2011-04-06 XenoPort, Inc. Promedicaments d'analogues de gaba, compositions et utilisations desdits promedicaments
WO2003077902A1 (fr) 2002-02-19 2003-09-25 Xenoport, Inc. Procede de synthese de promedicaments a partir de derives de 1-acyl-alkyl et compositions correspondantes
WO2003080588A1 (fr) 2002-03-20 2003-10-02 Xenoport Promedicaments 1-(acyloxy)-alkyle cyclique d'analogues de l'acide gamma-aminobutyrique, leurs compositions et leurs utilisations
US7183259B2 (en) 2002-05-17 2007-02-27 Xenoport Amino acid conjugates providing for sustained systemic concentrations of GABA analogues
US7060727B2 (en) 2002-12-11 2006-06-13 Xenoport, Inc. Prodrugs of fused GABA analogs, pharmaceutical compositions and uses thereof
AU2003283718A1 (en) * 2002-12-13 2004-07-09 Warner-Lambert Company Llc Gabapentin analogues for fibromyalgia and other related disorders
CA2451267A1 (fr) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Utilisations pharmaceutiques de ligands alpha2delta
WO2004093827A2 (fr) * 2003-03-25 2004-11-04 Kiel Laboratories, Inc. Sels d'acide phenolique de gabapentine en formes posologiques solides et procedes d'utilisation
EP1670451A4 (fr) 2003-09-11 2009-10-21 Xenoport Inc Traitement et/ou prevention de l'incontinence urinaire et promedicaments des analogues gaba
BRPI0414481A (pt) 2003-09-17 2006-11-14 Xenoport Inc métodos de tratamento ou de prevenção da sìndrome das pernas inquietas em um paciente e de melhoria do sono em um paciente com sìndrome das pernas inquietas, e, composição farmacêutica
KR101096480B1 (ko) 2003-10-14 2011-12-20 제노포트 인코포레이티드 감마-아미노부티르산 유사체의 결정질 형태
JP4613031B2 (ja) * 2004-05-06 2011-01-12 エスエス製薬株式会社 催眠剤組成物
JP2005325070A (ja) * 2004-05-14 2005-11-24 Ss Pharmaceut Co Ltd 睡眠改善剤
BRPI0517227B8 (pt) 2004-11-04 2021-05-25 Xenoport Inc comprimido oral de liberação prolongada do ácido 1-{[alfa-isobutanoiloxietoxi)carbonil]amino metil}-1-cicloexano acético, e, uso do comprimido
JP2009505947A (ja) 2005-06-23 2009-02-12 エモリー・ユニバーシティ 画像化剤
KR20070070307A (ko) * 2005-08-24 2007-07-04 에스에스 세야쿠 가부시키 가이샤 수면 개선 의약 조성물
CA2640402C (fr) * 2006-03-06 2012-01-03 Pfizer Products Inc. Ligands alpha-2-delta pour sommeil non reparateur
EP2250148B1 (fr) 2008-01-25 2016-08-17 XenoPort, Inc. Forme cristalline de sels de calcium d'acide (3s)-aminomethyl-5-methyl-hexanoique et ses procedes d'utilisation
US7868043B2 (en) 2008-01-25 2011-01-11 Xenoport, Inc. Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
CA2706575C (fr) 2008-01-25 2015-07-14 Xenoport, Inc. Resolution des enantiomeres de thiocarbonates d'acyloxyalkyle utilises dans la synthese de precurseurs de carbamates d'acyloxyalkyle
AU2009302241B2 (en) 2008-10-08 2015-10-29 Xgene Pharmaceutical Inc. GABA conjugates and methods of use thereof
WO2011071995A2 (fr) 2009-12-08 2011-06-16 Case Western Reserve University Composés et procédés de traitement de troubles oculaires
US9066853B2 (en) 2013-01-15 2015-06-30 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable fiber
AU2014209028C1 (en) 2013-01-28 2019-08-29 Hector L. Lopez Methods of improving tolerability, pharmacodynamics, and efficacy of b-alanine and use therefor
SG11201811368SA (en) * 2016-05-26 2019-01-30 Amino Up Chemical Co Ltd Sleep improving agent
WO2019219000A1 (fr) 2018-05-14 2019-11-21 Xgene Pharmaceutical Inc. Formes cristallines de conjugués de médicament 1- (acyloxy) -alkyle carbamate de naproxène et de prégabaline

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087544A (en) 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de) 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US5084479A (en) 1990-01-02 1992-01-28 Warner-Lambert Company Novel methods for treating neurodegenerative diseases
US6197819B1 (en) 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
US5510381A (en) 1995-05-15 1996-04-23 Warner-Lambert Company Method of treatment of mania and bipolar disorder
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
DE69709070T2 (de) * 1996-03-14 2002-06-20 Warner Lambert Co Verbrückte zyklische aminosäuren als pharmazeutische mittel
US6372792B1 (en) * 1996-04-26 2002-04-16 Guy Chouinard Method for treating anxiety, anxiety disorders and insomnia
GEP20094817B (en) 1997-10-27 2009-11-10 Warner Lambert Co Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
NZ509231A (en) * 1998-07-09 2003-08-29 Warner Lambert Co Use of GABA analogs to treat insomnia
ES2185591T3 (es) * 1999-06-02 2003-05-01 Warner Lambert Co Amino hererociclos utiles como agentes farmaceuticos.
HN2000000224A (es) * 1999-10-20 2001-04-11 Warner Lambert Co Aminoacidos biciclicos como agentes farmaceuticos
EP1237847B1 (fr) 1999-12-08 2006-05-17 Warner-Lambert Company Llc Methode de synthese stereoselective d'acides amines cycliques
GB9930083D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
US7141606B2 (en) 2006-11-28
WO2002000209A2 (fr) 2002-01-03
JP2004501189A (ja) 2004-01-15
DE60133389D1 (de) 2008-05-08
EP1296671B1 (fr) 2008-03-26
KR20030019455A (ko) 2003-03-06
IL152770A0 (en) 2003-06-24
TWI298020B (en) 2008-06-21
HUP0300833A2 (hu) 2003-08-28
BR0111913A (pt) 2004-01-06
ES2300332T3 (es) 2008-06-16
CZ20024110A3 (cs) 2003-10-15
NZ522480A (en) 2005-06-24
CA2414008A1 (fr) 2002-01-03
JP3909842B2 (ja) 2007-04-25
AU2001264736B2 (en) 2006-04-27
MXPA02010668A (es) 2003-03-10
PL359872A1 (en) 2004-09-06
PT1296671E (pt) 2008-05-09
US20030212133A1 (en) 2003-11-13
SK17922002A3 (sk) 2003-11-04
DE60133389T2 (de) 2008-06-26
EP1296671A2 (fr) 2003-04-02
KR100785182B1 (ko) 2007-12-11
CA2414008C (fr) 2011-04-26
ATE390133T1 (de) 2008-04-15
WO2002000209A3 (fr) 2003-01-16
CN1279900C (zh) 2006-10-18
CN1436075A (zh) 2003-08-13
ZA200209418B (en) 2005-03-10
IL152770A (en) 2009-12-24
AU6473601A (en) 2002-01-08
HUP0300833A3 (en) 2009-08-28
HK1056681A1 (en) 2004-02-27

Similar Documents

Publication Publication Date Title
DK1296671T3 (da) Gabapentinanaloger til sövnforstyrrelser
GB0223040D0 (en) Therapeutic compounds
BG106586A (en) Pyrazolopyramidines as therapeutic agents
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
DE60124684D1 (de) Sulfonamido-substituierte verbrückte bicycloalkylderivative
GB0005251D0 (en) Therapeutic compounds
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
GB0108592D0 (en) Therapeutic agents
ATE350375T1 (de) 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen- abhängigen erkrankungen
GB0108591D0 (en) Therapeutic agents
DE60223694D1 (de) Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums
IS6069A (is) N-cýanómetýlamíð sem próteasalatar
PL373903A1 (en) A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease
CY2009002I1 (el) Χρηση αμινοξικων αντισπασμωδικων για τη θεραπευτικη αγωγη του πονου
TR200101120T2 (tr) Serin proteaz inhibitörü
SE9603669D0 (sv) New combination
ATE357438T1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
DE60205899D1 (en) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
BR0314844A (pt) Novo composto
ATE432068T1 (de) Cetirizin und pseudoephedrin enthaltende tablette
PL376894A1 (pl) Pochodne 4-(fenylopiperazynylometylo) benzamidu i ich zastosowanie do leczenia bólu lub zaburzeń żołądkowo-jelitowych
BR0314843A (pt) Novo composto
PL376895A1 (pl) Pochodne 4-(fenylopiperazynylometylo) benzamidu i ich zastosowanie do leczenia bólu lub zaburzeń żołądkowo-jelitowych
IS6087A (is) N-(2-fenýl-4-amínó-bútýl)-1-naftamíð sem virka á móti taugakínín-1 viðtaka
AU2003303141A8 (en) Hydroxypropyl amides for the treatment of alzheimer's disease